海外招聘者

2026年8月12日時点
アルファベット順・敬称略

	Chieh Hwee Ang Singapore General Hospital 【Speaker】Asian Joint Panel Discussion Hematologic malignancies in adolescents and young adults
	Belinda Avalos Professor, Wake Forest University School of Medicine Senior Advisor, Atrium Health Levine Cancer Member, Atrium Health Wake Forest Baptist Comprehensive Cancer Center 【Speaker】Women Physicians Career Symposium Empowering Women in Hematology: Where We Stand Globally and in Japan
	Stefanie R. Bailey University of Virginia Department of Pediatrics Division of Pediatric Hematology/Oncology 【Speaker】Symposium 8 Cutting Edge of CAR T cell research
	Nancy L. Bartlett Washington University in St. Louis Siteman Cancer Center 【Speaker】JSH-ASH Joint Symposium Recent Advances in Lymphoma Biology and Treatment Development
	Monique den Boer Princess Máxima Center for Pediatric Oncology 【Speaker】Symposium 1 Acute leukemia, recent advances in elucidating the genetic, epigenetic and molecular pathogenesis
	Mario Cazzola Department of Molecular Medicine, University of Pavia 【Speaker】JSH-EHA Joint Symposium Advances in research and treatment of MDS
	Tathagata Chatterjee Senior Professor Haematology, ESIC Medical College, Faridabad, India 【Speaker】Asian Joint Panel Discussion Hematologic malignancies in adolescents and young adults
	Luciano Costa Mary and Bill Battle Professor in Multiple Myeloma Director Multiple Myeloma Program UAB, The University of Alabama at Birmingham 【Speaker】Symposium 6 Personalized treatment for multiple myeloma
	John E. Dick Princess Margaret Cancer Centre/University Health Network 【Speaker】Special Lecture 2 What makes a stem cell a stem cell and how does it go bad
	Hartmut Döhner University Hospital of Ulm 【Speaker】Symposium 1 Acute leukemia, recent advances in elucidating the genetic, epigenetic and molecular pathogenesis
	Konstanze Döhner Section Myeloid Neoplasms, Department of Internal Medicine III, University Hospital of Ulm, Germany 【Speaker】EHA Special Lecture Novel aspects in the management of AML patients with FLT3 mutations 【Chair】JSH-EHA Joint Symposium Advances in research and treatment of MDS 【Speaker】Women Physicians Career Symposium Empowering Women in Hematology: Where We Stand Globally and in Japan 【Chair】JSH-EHA Travel Grant Awardee's Session in JSH2026
	Ulrike Gerdemann The Dana-Farber/Boston Children's Cancer and Blood Disorders Center 【Speaker】Symposium 8 Cutting Edge of CAR T cell research
	Gregory M. Goldgof Director, Artificial Intelligence and Computational Hematopathology Department of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center 【Speaker】Symposium 2 Artificial Intelligence-Assisted Acceleration of Hematopoiesis Research
	Eva Hellström Lindberg Karolinska Institutet 【Speaker】JSH-EHA Joint Symposium Advances in research and treatment of MDS
	Mei Heng Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China 【Speaker】Asian Joint Panel Discussion Hematologic malignancies in adolescents and young adults
	Kyung Taek Hong Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine 【Speaker】Asian Joint Panel Discussion Hematologic malignancies in adolescents and young adults
	Steven Horwitz Memorial Sloan Kettering Cancer Center 【Speaker】JSH-ASH Joint Symposium Recent Advances in Lymphoma Biology and Treatment Development 【Commentator】SETP Lymphoma
	Yu Hu Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China 【Chair】Asian Joint Panel Discussion Hematologic malignancies in adolescents and young adults
	Elias Jabbour MD Anderson Cancer Center 【Speaker】Symposium 3 Pioneers and Game Changers: New Horizons in Leukemia 【Commentator】SETP Clinical challenge for leukemia
	Siddhartha Jaiswal Stanford University 【Speaker】Presidential Symposium 2 Next-Generation Insights into Myeloid Neoplasms
	Paula James Queen's University 【Speaker】Symposium 7 Bleeding disorder of unknown cause (BDUC)
	Mark J. Levis Johns Hopkins University 【Speaker】Symposium 5 Minimal Residual Disease and Post-Transplant Maintenance Therapy
	Jaroslaw Maciejewski Cleveland Clinic, Taussig Cancer Center 【Speaker】Presidential Symposium 1 Germline predisposition to somatic evolution
	Guillermo Garcia-Manero MD Anderson Cancer Center 【Speaker】Presidential Symposium 2 Next-Generation Insights into Myeloid Neoplasms
	Salomon Manier Lille University Hospital 【Speaker】Symposium 6 Personalized treatment for multiple myeloma
	Charles Mullighan St. Jude Children's Research Hospital 【Speaker】Symposium 3 Pioneers and Game Changers: New Horizons in Leukemia
	Satu Mustjoki University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center 【Speaker】Symposium 4 Recent insights in molecular pathogenesis of bone marrow failure
	Robert Negrin Stanford University 【Speaker】ASH Special Lecture The role of regulatory T cells to improve outcomes following allogeneic transplantation 【Chair】JSH-ASH Joint Symposium Recent Advances in Lymphoma Biology and Treatment Development 【Commentator】SETP Stem cell biology
	Aaron Newman Stanford University, Department of Biomedical Data Science / Institute for Stem Cell Biology and Regenerative Medicine 【Speaker】Symposium 2 Artificial Intelligence-Assisted Acceleration of Hematopoiesis Research
	Samantha Nier Acute Leukemia Advocates Network (ALAN) 【Speaker】Patient and Public Involvement Symposium Connecting Patient Voices to Society and International Networks— Patient Organisation Collaboration, PPI, and Global Perspectives
	Esther Natalie Oliva London North West University Healthcare NHS Trust 【Speaker】Keynote Lecture From precision medicine to precision care: integrating quality of life into modern hematology
	Daniel Pollyea University of Colorado School of Medicine 【Speaker】Educational Lecture 3-4-6 Resistance to BCL-2 Inhibition in AML
	Chantana Polprasert Center of Excellence in Translational Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital 【Speaker】Asian Joint Panel Discussion Hematologic malignancies in adolescents and young adults
	Annalisa Ruggeri Hematology and BMT, IRCCS San Raffaele Hospital, Milano, Italy 【Speaker】Symposium 5 Minimal Residual Disease and Post-Transplant Maintenance Therapy
	Timm Schroeder Department of Biosystems Science and Engineering ETH Zurich in Basel 【Speaker】Symposium 2 Artificial Intelligence-Assisted Acceleration of Hematopoiesis Research
	Akiko Shimamura Boston Children’s Hospital, Dana Farber Cancer Institute, Harvard Medical School 【Speaker】Symposium 4 Recent insights in molecular pathogenesis of bone marrow failure 【Commentator】SETP Genomic analysis for hematologic malignancy
	Jean Soulier Paris Saint-Louis Leukemia Institute and University Paris Cité 【Speaker】Presidential Symposium 1 Germline predisposition to somatic evolution
	Will Thomas Cambridge University Hospitals NHS Foundation Trust 【Speaker】Symposium 7 Bleeding disorder of unknown cause (BDUC)
	Marcin Wlodarski St. Jude Children’s Research Hospital 【Speaker】Presidential Symposium 1 Germline predisposition to somatic evolution
	Yung-Li Yang Department of Laboratory Medicine, College of Medicine. National Taiwan University Hospital 【Speaker】Asian Joint Panel Discussion Hematologic malignancies in adolescents and young adults